4//SEC Filing
MORNEAU MICHAEL 4
Accession 0001209191-20-004311
CIK 0001607678other
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 5:35 PM ET
Size
5.0 KB
Accession
0001209191-20-004311
Insider Transaction Report
Form 4
MORNEAU MICHAEL
Chief Financial Officer
Transactions
- Tax Payment
Common Stock, par value $0.00001 per share
2020-01-19$7.18/sh−2,044$14,676→ 92,840 total
Footnotes (2)
- [F1]These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain shares of restricted stock units.
- [F2]Includes 2,893 shares acquired on May 20, 2019 and November 20, 2019 pursuant to the Issuer's 2014 Employee Stock Purchase Plan.
Documents
Issuer
Viking Therapeutics, Inc.
CIK 0001607678
Entity typeother
Related Parties
1- filerCIK 0001517780
Filing Metadata
- Form type
- 4
- Filed
- Jan 20, 7:00 PM ET
- Accepted
- Jan 21, 5:35 PM ET
- Size
- 5.0 KB